All terms in GO
| Label | Id | Description |
|---|---|---|
| GO_0031212 | GO_0031212 | |
| RNA-dependent DNA biosynthetic process | GO_0006278 | [A DNA biosynthetic process that uses RNA as a template for RNA-dependent DNA polymerases (e.g. reverse transcriptase) that synthesize the new strand.] |
| premeiotic DNA replication | GO_0006279 | [The replication of DNA that precedes meiotic cell division.] |
| RSF complex | GO_0031213 | [An ISWI complex that contains an ATPase subunit of the ISWI family (SNF2H in mammals) and an RSF1 homolog. It mediates nucleosome deposition and generates regularly spaced nucleosome arrays. In mammals, RSF is involved in regulation of transcription from RNA polymerase II promoters).] |
| ISWI-type complex | GO_0031010 | [Any nuclear protein complex that contains an ATPase subunit of the imitation switch (ISWI) family. ISWI ATPases are involved in assembling chromatin and in sliding and spacing nucleosomes to regulate transcription of nuclear RNA polymerases I, II, and III and also DNA replication, recombination and repair.] |
| negative regulation of pole plasm oskar mRNA localization | GO_0045855 | [Any process that stops, prevents, or reduces the frequency, rate or extent of a process in which oskar mRNA is transported to, or maintained in, the oocyte pole plasm.] |
| negative regulation of embryonic pattern specification | GO_1902876 | [Any process that stops, prevents or reduces the frequency, rate or extent of embryonic pattern specification.] |
| regulation of pole plasm oskar mRNA localization | GO_0007317 | [Any process that modulates the frequency, rate or extent of the process in which oskar mRNA is transported to, or maintained in, the oocyte pole plasm.] |
| negative regulation of intracellular mRNA localization | GO_1904581 | [Any process that stops, prevents or reduces the frequency, rate or extent of intracellular mRNA localization.] |
| negative regulation of oocyte development | GO_0060283 | [Any process that decreases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.] |
| pole plasm oskar mRNA localization | GO_0045451 | [Any process in which oskar mRNA is transported to, or maintained in, the oocyte pole plasm.] |
| positive regulation of pole plasm oskar mRNA localization | GO_0045856 | [Any process that activates or increases the frequency, rate or extent of the process in which oskar mRNA is transported to, or maintained in, the oocyte pole plasm.] |
| positive regulation of embryonic pattern specification | GO_1902877 | [Any process that activates or increases the frequency, rate or extent of embryonic pattern specification.] |
| positive regulation of oocyte development | GO_0060282 | [Any process that increases the rate or extent of the process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.] |
| positive regulation of intracellular mRNA localization | GO_1904582 | [Any process that activates or increases the frequency, rate or extent of intracellular mRNA localization.] |
| negative regulation of molecular function, epigenetic | GO_0045857 | [Any heritable epigenetic process that stops, prevents, or reduces the frequency, rate or extent of protein function by self-perpetuating conformational conversions of normal proteins in healthy cells. This is distinct from, though mechanistically analogous to, disease states associated with prion propagation and amyloidogenesis. A single protein, if it carries a glutamine/asparagine-rich ('prion') domain, can sometimes stably exist in at least two distinct physical states, each associated with a different phenotype; propagation of one of these traits is achieved by a self-perpetuating change in the protein from one form to the other, mediated by conformational changes in the glutamine/asparagine-rich domain. Prion domains are both modular and transferable to other proteins, on which they can confer a heritable epigenetic alteration of function; existing bioinformatics data indicate that they are rare in non-eukarya, but common in eukarya.] |
| regulation of molecular function, epigenetic | GO_0040030 | [Any heritable epigenetic process that modulates the frequency, rate or extent of protein function by self-perpetuating conformational conversions of normal proteins in healthy cells. This is distinct from, though mechanistically analogous to, disease states associated with prion propagation and amyloidogenesis. A single protein, if it carries a glutamine/asparagine-rich ('prion') domain, can sometimes stably exist in at least two distinct physical states, each associated with a different phenotype; propagation of one of these traits is achieved by a self-perpetuating change in the protein from one form to the other, mediated by conformational changes in the glutamine/asparagine-rich domain. Prion domains are both modular and transferable to other proteins, on which they can confer a heritable epigenetic alteration of function; existing bioinformatics data indicate that they are rare in non-eukarya, but common in eukarya.] |
| positive regulation of molecular function, epigenetic | GO_0045858 | [Any heritable epigenetic process that increases the frequency, rate or extent of protein function by self-perpetuating conformational conversions of normal proteins in healthy cells. This is distinct from, though mechanistically analogous to, disease states associated with prion propagation and amyloidogenesis. A single protein, if it carries a glutamine/asparagine-rich ('prion') domain, can sometimes stably exist in at least two distinct physical states, each associated with a different phenotype; propagation of one of these traits is achieved by a self-perpetuating change in the protein from one form to the other, mediated by conformational changes in the glutamine/asparagine-rich domain. Prion domains are both modular and transferable to other proteins, on which they can confer a heritable epigenetic alteration of function; existing bioinformatics data indicate that they are rare in non-eukarya, but common in eukarya.] |
| positive regulation of nurse cell apoptotic process | GO_0045850 | [Any process that activates or increases the frequency, rate or extent of nurse cell apoptotic process.] |
| positive regulation of oogenesis | GO_1905881 | [Any process that activates or increases the frequency, rate or extent of oogenesis.] |